Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ofatumumab for Multiple Sclerosis
Recruiting2 awardsPhase 3
Washington, District of Columbia
This trial will test a new dose of a drug called ofatumumab in people with relapsing multiple sclerosis to see how the body processes the drug, how it affects the body, and if
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service